Citace podle APA

Zhou, A., Bai, Y., Song, Y., Luo, H., Ren, X., Wang, X., . . . Ma, J. (2019). Anlotinib Versus Sunitinib as First‐Line Treatment for Metastatic Renal Cell Carcinoma: A Randomized Phase II Clinical Trial. Oncologist.

Styl Chicago

Zhou, Ai‐Ping, et al. "Anlotinib Versus Sunitinib As First‐Line Treatment for Metastatic Renal Cell Carcinoma: A Randomized Phase II Clinical Trial." Oncologist 2019.

Citace podle MLA

Zhou, Ai‐Ping, et al. "Anlotinib Versus Sunitinib As First‐Line Treatment for Metastatic Renal Cell Carcinoma: A Randomized Phase II Clinical Trial." Oncologist 2019.

Upozornění: Tyto citace jsou generovány automaticky. Nemusí být zcela správně podle citačních pravidel..